|
Management E. Greg McCartney is president & director. He is owner & director of Aspenwood Holdings Corp., a business consulting firm specializing in developing companies in technology & manufacturing industries. .... Dr. Paul R. Ervin, Jr. PhD, director, is founder & president of Biotherapies, Inc., founder & managing director of the Mammastatin Research Institute, & former research scientist at the University of Michigan's Cancer Research Institute. He is credited with the discovery of mammastatin as a protein that controls breast cancer growth. He is currently conducting FDA clinical tests on the mammastatin diagnostic & therapeutic product lines. .... Dr. Ian B. Woods, PhD, MD is VP operations & director. He is senior founding partner of Burke Mountain Medical Centre in Port Coquitlam, Canada. He also served for the past 20 years on the Medical Advisory, Pediatric Advisory, & Medical Manpower Committees at the Royal Columbian Hospital in New Westminster, Canada. .... Lawrence J. Pasemko is secre-tary/treasurer/director. He is the owner of Tynehead Capital Corp,. a management & consulting firm specializing in assisting start-up & development stage businesses. He has over 30 years experience in business management, marketing, & administra-tion. Financial Status (9/30/98) Current Assets: $92,000 * The joint venture & BILB await FDA sanction of the product prior to starting to sell test kits. Recommendation I recommend BILB for both midterm & long-term apprecia-tion. I feel this situation is on the brink of significant growth. Its research indicates that its MSA kit will find wide acceptance by both consumers & medical professionals. Rosanne says: "Any substitute such as a blood test would be far more acceptable to women. The mammogram procedure is very uncomfortable." Here are other things I like:
Contact The company is at 1A - 3033 King George Hwy, Surrey, BC, Canada V4P 1B8. Call 604-542-0820; fax 604-542-0821. www.biola-bs.com or www.marketmanagement.com For broker & investor data, call Dewayne Lockhart, Capital Media Group at 704-365-9147. e-mail: cmgir@worldnet.att.net |
These comments apply to every situation mentioned in Conservative Speculator. Special situation, low-priced, micro-cap, & high-gain-potential stocks have high risk. Fortunately, not many speculative situations turn out to be disasters, but some do -- that is a risk you must accept. "Winning Investment Strategies," my 60-page guide to speculative investing, is made available to every regular CS subscriber. Stated extremely briefly, here are three of my most important strategies: (1) Be prudent -- the total funds allocated to speculative stocks should be limited to a small percentage of your cash, certainly no more than you could lose without discomfort. I then suggest no more than 5% of that small portion be invested in any one stock, to spread your risk. .... (2) Do not accept my opinion as the reason to invest. Call the company. Get a feel yourself. If you are not totally comfortable, pass. I give you an ample number of possibilities. My task is to expose you to potentially profitable situations. You have the responsibility of making any investment decision. Do not give up that responsibility. (3) Since in a monthly newsletter it is not possible to tell you when to sell, apply a moving stop-loss strategy. If the price goes up, raise your stop-loss guideline point to something like 20% below the new price. Keep doing that as the price rises. If the price goes down to your stop-loss point, grit your teeth & sell. This limits loss, but lets profits increase. These are capsule updates on previously recommended companies that provided us with substantive news during the past month. I also include updates on some Sneak Previews where our investigation has resulted in additional pertinent information. I do not have room for all details, but always include the company's phone number so you can follow through. ...continued on next page, click here |
|
|
|
Disclaimer: The public companies featured in the Corporate Profiles listed in the "Special Situation" section on the Home Page of www.WallStreetCorner.com are our regular clients. Each such client pays an annual cash fee of $12,000, or alternatively, a monthly cash fee of $495 plus a negotiated number of Form 144 restricted shares for our service. We on rare occasions accept free-trading shares, but we usually hold such shares for the long pull - we do not engage in trading. Such fees are disclosed as part of the Corporate Profile prepared and posted on the particular company involved. The basic coverage provided to such clients primarily includes the preparation of their Corporate Profile, posting it here at WallStreetCorner.com, and the distribution of email alerts to our international database of investors and financial professionals when their Profile is initially posted, and each time their Profile is subsequently updated. We expect our clients to work with us in a team effort by calling us each time they have achieved a significant milestone. We then update their Profile and issue an additional email alert to our totally opt-in email database (as of July 2008, members of that database are from over 96 countries). The email distributions we make are a key element of our service -- those, as well as the updated Corporate Profile are what together are designed to achieve a gradual buildup of new shareholders who generally hold for the long term. If you are an officer at a public company and want the exposure afforded at WallStreetCorner.com, email Larry at up415@aol.com or call him at 843-645-2729. Information displayed by WallStreetCorner in its Corporate Profiles, and in its editorial or other columns, does not constitute an offer to buy, sell, or trade a security of any kind, including stock. Larry Oakley, and/or WallStreetCorner.com, Inc., does not recommend that any person, institution, or other entity make any decisions or form any opinions, etc. based on the information on this site. All visitors to this site are urged to do two things before investing in any stock: (1) Call the company and ask questions -- if there is anything you do not like regarding such call, pass -- our goal is to bring you a selection of what we feel are growth situations with good long-term appreciation potential, but you must accept the responsibility of making your own decisions regarding which situations to invest in -- do not give up that responsibility; and (2) Consult a qualified financial professional before taking any actions in regards to buying, selling, or trading securities (stocks or other forms of equity). Companies covered in Conservative Speculator, a newsletter accessed from WallStreetCorner, or in any of Larry Oakley's other editorial venues ("Opinion," "Stock Pick," "Comment," and "Bold Ventures" columns, and in any other editorial venue to which Larry contributes) do not pay for such editorial coverage; the companies Larry covers editorially have never, do not now, and never will be charged for editorial coverage. The only paid portions of WallStreetCorner.com are the Profiles and email distributions (email distributions are a part of the client's package, but occasionally are paid for separately by non-clients - if a non-client wants to utilize our email distributions, the cost is $2,000 for the first distribution, $1,500 for the second, $1,000 for the third, and $500 for all subsequent distributions made for the same company). On occasion, Larry Oakley shares his opinion regarding a private company or its product or service. Bear in mind that nothing at that special section is an investment possibility. To see that section, click where on the home page it says: "Click here to access our Special Emerging Growth Situations." See the introductory portion of that special section for additional information regarding the material covered there. |
|
|
WallStreetCorner.com |
